KNSA:NASDAQ, Kiniksa Pharmaceuticals International, plc

KNSA stock overview

Kiniksa Pharmaceuticals International, plc (KNSA:NASDAQ) closed at $96.33 on November 13, 2026, up 0.05% on the day. The stock trades 3.0% below its 52-week high of $99.31 and 160.2% above its 52-week low of $37.02. Over the past year, it gained 138.9%. Kiniksa Pharmaceuticals International, plc is part of the Health Care sector (Major Pharmaceuticals).

Key figures

Price: $96.33
Day change: +0.05%
Volume: 464,982
Average volume: 667,318
Market cap: 7B+
52-week range: $37.02 – $99.31
50-day average: $81.86
200-day average: $62.57

Price action over the past year

In 252 trading sessions since November 13, 2025, KNSA closed higher on 136 days (54%). Its best day was July 28, 2026 (+25.03%) and its worst was February 24, 2026 (-8.21%). The stock moved 10% or more in a single session 3 times. It opened at least 5% above the previous day's high 3 times.

Recent signals

Nov 13, 2026: Trading sideways between $88.34 and $98.76 over 14 days (Sideways scanner)
Oct 27, 2026: News catalyst: Investor Update (News Catalysts scanner)

KNSA news

Nov 11, 2026: Kiniksa Pharmaceuticals to Present at Jefferies Global Healthcare Conference in London
Oct 30, 2026: Stock Market: Google, Amazon, Intel, ServiceNow Trigger Tech Wreck, But Other Sectors Solid: Weekly Review
Oct 28, 2026: Kiniksa (KNSA) Stock Jumps As Q3 Results Fuel Growth Debate
Oct 27, 2026: Kiniksa Pharmaceuticals: 3 Key Takeaways for Long-Term Investors
Oct 27, 2026: Kiniksa Pharmaceuticals, Ltd. Q3 2026 Earnings Call Summary
Oct 27, 2026: Kiniksa (KNSA) Q3 2026 Earnings Call Transcript
Oct 27, 2026: What Kiniksa Pharmaceuticals International (KNSA) Said on Its Q3 Earnings Call
Oct 27, 2026: Kiniksa Crushes Estimates As ARCALYST Crosses $1 Billion Run-Rate, But Guidance Implies A Costlier, Slower Q4

About Kiniksa Pharmaceuticals International, plc

Kiniksa Pharmaceuticals Ltd is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases.

Similar stocks

Find more stocks like KNSA with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.